Improving Lives? While cutting employees? How about you sell plants instead?

I’m reading that Acreage and PharmaCann are considering layoffs, tracking MSO lawsuits, and hearing threats to pull out of New York. I guess they thought the NY market was going to be easy? Maybe they misunderstood what “If you can make it here, you can make it anywhere” means. It’s New York. Of course it’s going to be tough.

I’m not sure why they are giving up though. They still have a HUGE advantage. As close followers of the homegrow regs know, Article 3 licensees (AKA MSOs AKA ROs) are currently the only companies who can legally sell seeds and clones in New York!

I’m a little surprised that they have been spending $15 or $20 Million bucks a year here for 10 years and still haven’t figured this out, but here’s a tip - have a clone drop! Steve DeAngleo told me that the busiest days at Harborside in Oakland were the days that they had new strains available for sale. And Meg Saunders up at Canna Provisions in Holyoke has lines around the block when her grower drops his clones.

Of course, it helps when Chemdog is your grower, but $200,000,000 ought to have at least left them with some decent genetics, right?

The price compression is here to stay, but seeds, clones and seedlings will have durable value. It’s a shame this big companies can’t see the opportunity right in front of them. Instead of working hard to make their business work, they are doing exactly what everybody is afraid they are going to do - demand an advantage so they can make money selling mids, and laying people off when they don’t get their way.

Previous
Previous

Patient Matching is tricky!

Next
Next

AURD Guidance and Plant Sales